Quantamental Technologies LLC Enanta Pharmaceuticals Inc Transaction History

Quantamental Technologies LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $165,255 - $333,414	4,334 New	4,334 $205,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $152,707 - $201,875	-2,724 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $163,957 - $265,235	2,724 New	2,724 $204,000
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $141,745 - $162,928	-2,446 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$60.08 - $88.17 $111,268 - $163,290	1,852 Added 311.78%	2,446 $147,000
Q2 2019 Aug 12, 2019	SELL	$81.3 - $97.35 $237,477 - $284,359	-2,921 Reduced 83.1%	594 $50,000
Q1 2019 Apr 29, 2019	BUY	$69.08 - $105.66 $242,816 - $371,394	3,515 New	3,515 $336,000

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $173M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.